Posts Tagged "project report online"

Opinions expressed by Entrepreneur contributors are their own.

Are you facing a moment, or the moment?

It’s a critical distinction we often lose sight of. When we’re facing a big decision, grappling with a change, or wondering whether to seize or pass on a new opportunity, we tend to raise the stakes on ourselves. We treat our decision as critical — as make-or-break, do-or-die. It’s the last train leaving the station! The game-winning shot in your hands! Everything seems to hang in the balance.

My advice: Take a breath. Calm your emotions. Then ask yourself my simple but profound question — are you facing a moment, or the moment?

I’ll give you an example.

My friend Jenny Illes Wood is high up at Google, and she has built a popular program there called Own Your Career. She gives workshops on how Googlers can increase their influence, develop new skills, better advocate for themselves, and so on, and tens of thousands of her colleagues subscribe to her email newsletter. She imagined that one day she might write a book inspired by all this — but she has two small kids and a busy job, so she was in no rush to do it.

Related: The 4 Actions You Must Take to Find Your Opportunity

Then a colleague introduced her to a book agent. The conversation went well. Jenny couldn’t stop herself; she talked to a few more agents. Suddenly she had multiple agents saying they wanted to work with her, and she was calling me in a panic. “I don’t know what to do,” she said. “I don’t have time to write a book, but I’m so excited and don’t want to miss this opportunity!”

So I asked her: Are you facing a moment, or the moment? Sometimes in life, we really do only get one shot. But most of the time, we get many shots. We can do something now, or we can do it later. Or maybe we never do it at all — it’s just one of many opportunities that we turn down, because we cannot do everything, and that’s OK.

In my estimation, I told her, she is facing a moment. If a book agent is interested now, then a book agent will be interested later. And in fact, she might benefit from writing a book later. She’ll have more time to develop material, she’ll have a larger public profile, and she’ll have even more Googlers on her mailing list. But that’s not to say it must happen later — she could also do it now and use the book to accelerate her other goals.

The point is, she should decide based on what’s best for her and the project, and not because she feels like this is her one chance to do it.

I have grappled with this myself, in many ways. I’ve struggled over whether to pursue jobs or say yes to new projects, all because I wasn’t sure if anything like them would ever come again. In fact, I’ve even grappled with Jenny’s same question about writing a book: I spent years on the fence, wondering when the time was right.

Related: Are You Too Efficient to Innovate?

Ultimately, I developed a way to answer these questions about timing. I started to think not about the opportunity in front of me, but about what I wanted the outcome of that opportunity to be. A job is not just a job; it’s a set of experiences and learnings. A project is not just a project; it’s an accomplishment that sets you up for future projects. The more we understand what we want from these things, and how they play a role in our larger vision of ourselves, the better we can decide if they’re something we need now, later, or never.

In my case, I see a book as the spark for larger opportunities. I wanted to make sure I understood what I wanted those opportunities to be, and that I had the people and infrastructure in place to take advantage of them. That’s why I waited for years, and why I finally said yes. My book, Build for Tomorrow, comes out in September!

Is it a moment, or the moment? That’s your starting point. And you’ll know when to act when you can finally say this: “It is my moment.”

We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

Opinions expressed by Entrepreneur contributors are their own.

A SPAC (Special-Purpose Acquisition Company), which can also be termed as a  “shell” or “blank check company”, is included in stock exchanges with the aim of gaining investment by means of public offers with the further confluence with an existing private company. Such entities are administered by the SEC (Securities and Exchange Commission in the United States).

As a rule, a SPAC must grab capital and acquire this or that company within 24 months. After that period, investors will get their funds back. Such entities exist in order to make it easier for nongovernment enterprises to attract investment, with minimum time and effort, so the process of Initial Public Offering listing can be dismissed. 

SPACs appeared in the 1990s and gained popularity in 2020 when investors had a stake in them. More than $13 billion were accumulated in 2019 but in 2020 this number increased to $83.3 billion involving over 50% of US entities that were officially listed on the stock exchange. During Q1 2021, the number had risen to $96 billion, and among listed companies, there were AdTech ones that showed significant success.

Let’s dig deeper into the matter of SPAC companies and find out what advantages they possess particularly for AdTech owners and partners. 

Related: BFLY: Is Butterfly Network a Buy Under $6?


Those businesses that choose to be included in public listings by means of SPAC take precedence over the traditional process of IPO listing.

First, the solution involving a SPAC is saving time and the whole process can be finished within several months whereas a traditional IPO requires more than one year. This is explained by the fact that there are fewer requirements to blank check companies and SPAC shares may be purchased by the public at large before a merger/acquisition. Apart from that, the process of IPO is not an easy way to go: it requires the solving of many issues concerning legal questions, marketing issues and accounting details. In addition, there’s no guarantee that the desired capital will be obtained.   

Moreover, the insecurity and fragility of the market caused by the Covid-19 pandemic made many businesses go the SPAC way. It helped them to set high stock prices and be able to maximize funds as well as keep the sustainability of share value. In most cases shell companies are usually controlled by experienced investors who know the ins and outs of private equity and thus business owners don’t have to worry about the forthcoming process of acquisition or convergence. Special funds-in-trust secure public investors’ share capital till merging. If it ends with elimination, these funds divide the share capital between the public stakeholders.


Shell companies’ investors might also face many risks. There’s no assurance that a merger will take place as expected or that it will happen at all. Some SPAC companies are missing proper control and disclosure and that may cause problems with investments, e.g. lead to fraudulent capital spend. 

There are no overhead expenses like commissions or salaries for the management staff before the acquisition or confluence takes place, so the company executives and the team are not always motivated to succeed. Moreover, there is also no basis for competing interests because it’s restricted for managers to unite with any party that is in affiliation with insiders unless stockholders acknowledge such merging.  

Revenues generated from SPAC companies may appear to be much lower than expected as the hype gradually decreases. According to Goldman Sachs, stocks of at least 70% of IPOs fueled by shell companies were worth less than $10 each.

Many SPAC companies tend to blend in with companies that need massive funding and have no certain financial projections. In such cases a SPAC is is the only way for them to attract capital as risks and possible speculations are rising.

Related: Financials Sector in 2022: What to Focus on This Year


Despite the controversy surrounding SPACs, AdTech companies seem to align the hype with the advertisement industry’s growth just fine. Last year, Taboola Inc. began trading with a $2.6B valuation and merged with ION Acquisition Corp 1 – a green flag for all industry players to put their feet on new ground. Another company that successfully merged with ION Acquisition Corp 1 for $1.3B was Innovid.

In 2021, AdTech investors had more opportunities to park their money for decent returns, from the $1B AdTheorent to $11.1B ironSource SPAC deals. In total, the first quarter of 2021 has seen a $23.7B-worth investment pool for advertising and marketing companies, where 67% came from mergers and acquisitions. 

In contrast to SPAC trends on a broader market, AdTech investors are satisfied with the revenue they receive as stock valuations are increasing. The reason is quite simple: programmatic keeps growing and delivering. According to the forecasts made by eMarketer, global digital ad spending will amount to nearly $650B by 2024, making it one of the fastest-growing areas of digital industries.

Unlike in other industries, there haven’t been any SPAC-related scandals in AdTech. Indeed, IronSource and Taboola had experienced some reduction in their valuation, but by the end of December 2021 the former company had fully recovered and the shares of the company were at an all-time high. Whether AdTech will have its own Nikola case remains to be seen. So far the biggest risks for reputation and share value are the ones associated with ad fraud – the activity which must be stopped before any pre-listing due diligence occurs.

As of today, SPACs remain the strongest tool for AdTech players to jump into public capital. With digital advertising, connected TV, and e-commerce establishing themselves as fixtures of “the new normal” amid the global pandemic, taking this road might be a great option to expand onto. In early 2022, we should expect to see more companies putting their SPAC plans on the table.

AdTech companies seeking additional funds might find SPAC a welcoming entry ticket to a public offering. It is true that some AdTech giants, including The Trade Desk and PubMatic have preferred IPOs, trading the extra potential cash for their privacy limitations, regulatory obligations, stricter financial controls, and so on. But not everyone is ready to take the hard road in a fast-paced world, which might still be on the brink of new lockdowns or significant regulatory changes.

Related: Why Strategic Venture Capital is Thriving in a Founder’s Market

We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

The stock market is in the midst of a brutal correction. Despite Monday’s bounce, investors should remain cautious as there remains a considerable downside risk. Read on to find out how the POWR Growth portfolio continues to outperform the S&P 500 (SPY). – StockNews

(Please enjoy this updated version of my weekly commentary published May 2nd, 2022 from the POWR Growth newsletter).

The market never makes it easy. For bulls or bears.

Today, the bears were looking and feeling like geniuses as the market broke below the February 24 low of 4,100 on the S&P 500 which has served as a key support line for the market and us. But, these feelings of satisfaction probably turned into grimaces as the market staged an impressive turnaround to finish the day in the green with our portfolio finishing up 1.3%.

In today’s commentary, I want to discuss why I’m not getting my hopes up despite this pleasant turn of events and what is concerning me at this moment. Then I’ll discuss the steps to take if the market does break below 4,100 decisively, and then some thoughts on China and energy. Finally, we will cover recent movements and earnings reports from our portfolio.

Market Commentary

As usual, we will start by reviewing the past week…

Here is an hourly, 3-week chart of the S&P 500:

Following last week’s 2.2% drop, we are down 3.3% this week for the S&P 500. And, at today’s low we would have been down 5.5%. An eery coincidence given that at last week’s low, we were down 4.4%.

We had slightly more pain in the Nasdaq and Russell 2000 which were down by 3.6% and 3.7%, respectively.

Not Getting My Hopes Up

Today’s bounce was clearly quite impressive, but I simply see it as more of the function of an oversold market with a very bearish sentiment. The nature of such markets is to have such bounces. And, these bounces could get even bigger, more violent, and explosive if we keep trending lower.

The market’s next catalyst is going to be the FOMC meeting in May 4 where expectations are for a 50 basis points hike with an outside chance of a 75 basis point hike. And, this is expected to kick off a series of 50 to 75 basis point hikes over the next few meetings.

It’s hard for me to see the market sustain a rally into such an event especially as the market is facing dual threats of inflation and a slowing economy.

What Concerns Me

As we’ve covered in previous commentaries, the bull case for the stock market was that the economy would grow fast enough to withstand the eroding effects of inflation.

I believe that the current weakness is due to investors seeing increasing odds of an economic downturn. And, this is primarily due to lockdowns continuing in China. But, we are also seeing many leading growth indicators start to roll over like ISM New Orders which often is an indication that the industrial sector is decelerating. Cyclical stocks are also pricing in a recession or a slowdown.

And, this scenario is the market’s worst fear. Slowing or negative growth means that earnings will decline, while higher rates mean that multiples contract.

Next Steps

As explained above, I’m having a tough time getting too enthused about today’s bounce. And a retest of the 4,100 level seems inevitable with the FOMC meeting coming up. Another thing that I’m seeing is that earnings are great, but stocks are popping and then finishing red which is consistent with investors seeing an earnings slowdown.

So, the next step for our portfolio is to get even more defensive if we break below 4,100 as this would be an indication that the intermediate trend is now down for the market.


The lockdowns and restrictions in China are a big deal. Mobility and activity measures in the country are at early 2020 levels in many parts of the country. Further, it’s already exacerbating supply chains and transportation bottlenecks which had just started to heal.

Basically, it’s not good when the second-largest economy in the world is knocked offline, and the normalization of the economy in terms of supply chains is likely pushed back another few months.

According to analysts, the CCP has pursued a zero-COVID policy over the last 2 years over vaccinations and boosters. In addition, the Chinese vaccines simply haven’t been effective. Therefore, a pivot is unlikely especially as local and regional political leaders are being evaluated based on case counts.

Based on the US, we know that the omicron outbreak ran out of steam after about 6 weeks. Due to vaccines and better treatments, deaths and hospitalizations didn’t materially rise like previous waves.

China is in a different place due to its system of government, policies, and lack of protection whether it’s prior infections or vaccines.


I wanted to check in on energy. Currently, oil is at $105 where it’s been consolidating since its drop from $135. I’m finding oil’s resilience quite impressive especially given the decline in demand from China.

What happens when this comes back?

So, I’m watching with interest, and my expectation is that energy will once again outperform when we emerge from this correction.

What To Do Next?

The POWR Growth portfolio was launched in April last year and has significantly outperformed the S&P 500 since then.

What is the secret to success?

The portfolio gets most of its fresh picks from the Top 10 Growth Stocks strategy which has stellar +48.22% annual returns.

If you would like to see the current portfolio of growth stocks, and be alerted to our next timely trades, then consider starting a 30 day trial by clicking the link below.

About POWR Growth newsletter & 30 Day Trial

All the Best,

Jaimini Desai
Chief Growth Strategist
Editor of the POWR Growth Newsletter

SPY shares fell $1.30 (-0.31%) in premarket trading Tuesday. Year-to-date, SPY has declined -12.46%, versus a % rise in the benchmark S&P 500 index during the same period.

About the Author: Jaimini Desai

Jaimini Desai has been a financial writer and reporter for nearly a decade. His goal is to help readers identify risks and opportunities in the markets. He is the Chief Growth Strategist for and the editor of the POWR Growth and POWR Stocks Under $10 newsletters. Learn more about Jaimini’s background, along with links to his most recent articles.


The post Is This a Bull Trap? appeared first on

We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

Commodities have been in a major bull market. Due to strong demand and lower production, the bull market is in its early innings. Read on to find out why Nexa Resources (NEXA) is one of the most undervalued and top commodity stocks. – StockNews

Over the last year, commodities have outperformed stocks and bonds by a significant degree. This bull market should continue as supply and demand fundamentals remain supportive. 

Despite strong price appreciation, CAPEX has remained quite low. So far, companies are using their increased cash flow to pay off debt and return money to shareholders via buybacks and dividends. Until we see a meaningful response on the supply side, dips should be bought. 

Of course, commodities are a broad category, but some of the best opportunities can be found in miners of industrial metals. One industrial metal with particularly strong fundamentals is zinc. Zinc is used to galvanize steel and iron or for alloying. There is even hope that it can be used instead of lithium for EV batteries which would bring tremendous cost and environmental benefits. Russia supplies about 7% of the world’s zinc, so zinc prices are up 20% since the buildup of troops on the Ukrainian border began.

Today, I want to talk about Nexa Resources (NEXA), which is one of the top zinc producers in the world. Read on to find out why it’s my stock of the week… 

Company Background

NEXA produces a variety of metals including zinc, silver, gold, and copper. But, zinc is its primary source of revenue. Another source of revenue is its smelting operation. It currently owns and operates 5 underground polymetallic mines that are located in Brazil and Peru.

Prior to September 2017, the company was known as VM Holding S.A., before it changed its name to Nexa Resources S.A. The company was founded in 1956 and is based in Luxembourg City, Luxembourg, and is a subsidiary of Votorantim S.A. In its last quarter, the company produced 66,000 tons of zinc. Its cost of production was $45 per ton. Of course, the company’s earnings have exploded due to the bull market in zinc.

Zinc Supply and Demand

Although zinc prices have backed off in the last couple of weeks, they remain within striking distance of 14-year highs due to strong industrial demand and lower production due to the coronavirus. Another recent catalyst for zinc is that smelting operations in Europe are running at below capacity due to high energy prices.

In 2022, analysts are expecting zinc demand to increase by 2.2% with the primary driver being increased auto production as the chip shortage eases. Recent coronavirus outbreaks in Asia have dented demand in Q1, but this should increase as the virus burns out. 

Over the next 2 years, analysts are expecting output to increase and normalize at higher levels. But demand should increase as well due to strength in the industrial economy, increased infrastructure spending, and more investment in offshore energy production.


Due to zinc prices rising from under $2,000 per ton to over $4,000 per ton over the last 2 years, it’s not surprising that NEXA’s earnings are booming. In its last quarter, the company reported $0.48 per share in earnings, a 182% increase from last year. The company’s revenue was up 20%. 

These figures should only increase given that zinc prices are up 20% YTD. For 2022, analysts are forecasting $2.32 in EPS and $2.93 billion in revenue. And, this forecast is based on zinc prices averaging $3,600 for the year, while we are already more than 10% above these levels which means more upgrades are likely.

This type of performance in 2022 also means that the stock is very attractively priced with a forward P/E of 4. The company has a market cap of $1.4 billion and nearly $800 million in cash. It also pays a generous dividend of 3.5% which it has maintained since becoming public in 2014. 

This makes NEXA an excellent ‘growth at a reasonable price’ (GARP) stock. 

POWR Ratings

NEXA’s attractive valuation provides a downside cushion. Earnings growth should continue due to rising zinc prices. And, zinc prices should continue to be supported as long as Europe is dealing with high electricity prices. 

In the intermediate-term, more supply of zinc should be hitting the market due to more mines coming back online and transportation bottlenecks easing. This could certainly lead to a pullback or some profit-taking.

But in the long-term, demand should continue to grow given that zinc is essential for so many uses. And, the world has underinvested in new production. Historically, commodity bull markets don’t end until there is a sufficient supply response.

These strong fundamentals are reflected in NEXA’s POWR Ratings. The stock has an overall B rating, equating to a Buy in our proprietary rating system. B-rated stocks have posted an annual performance of 21.1%, outpacing the S&P 500’s annual 8.0% performance. 

It’s also a standout in terms of component grades, NEXA has a B for Value due to having a P/E of 11 which is half of the S&P 500, and one of the top price-to-growth (PEG) ratios in the market. The stock is ranked #11 of 47 stocks in the Miners – Diversified industry. Click here to see the complete POWR Ratings for NEXA.

What To Do Next?

If you’d like to see more top stocks under $10, then you should check out our free special report: 3 Stocks to DOUBLE This Year

What gives these stocks the right stuff to become big winners?

First, because they are all low priced companies with explosive growth potential, that excel in key areas of growth, sentiment and momentum.

But even more important is that they are all top Buy rated stocks according to our coveted POWR Ratings system, Yes, that same system where top-rated stocks have averaged a +31.10% annual return.

Click below now to see these 3 exciting stocks which could double (or more!) in the year ahead:

3 Stocks to DOUBLE This Year


NEXA shares closed at $9.36 on Friday, up $0.03 (+0.32%). Year-to-date, NEXA has gained 24.07%, versus a -12.99% rise in the benchmark S&P 500 index during the same period.

About the Author: Jaimini Desai

Jaimini Desai has been a financial writer and reporter for nearly a decade. His goal is to help readers identify risks and opportunities in the markets. He is the Chief Growth Strategist for and the editor of the POWR Growth and POWR Stocks Under $10 newsletters. Learn more about Jaimini’s background, along with links to his most recent articles.


The post This Undervalued Commodity Stock Has Major Upside in 2022 appeared first on

We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

Disclosure: Our goal is to feature products and services that we think you’ll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from our commerce partners.

There are some essential things in life that many of us tend to procrastinate. For young parents, the list of responsibilities you acquire feels ever-mounting, and so doing simple, important things like signing up for life insurance can often fall by the wayside. When getting a policy is known to take a long time, and we live in a digital age that gets faster by the minute, it’s understandable that barely over half of U.S. adults are covered.


At the same time, it’s not uncommon to talk to someone who does have coverage and wishes that they had secured a policy when they were younger. So if your family and career are growing, don’t waste any more time. You can get a quote and secure a policy in no time with Haven Life Insurance Agency. Backed and owned by MassMutual, this new-age provider offers an online application system that adds modern speed to over a century’s worth of experience in the insurance industry.

When you get started using the quote tool on Haven Life’s website, all you need to do is answer a few simple questions about who you are, where you’re from, and the depth of coverage you need. From there, the intuitive system will generate a quote for one of two coverage options. First, there is Haven Term, which is a medically underwritten life insurance policy that can pay out up to $3 million1 in coverage. There’s also Haven Simple — a new-age option that enables you to secure life insurance entirely online without being required to take a medical exam2 to finalize your coverage.

To get an idea of the range of policies, here’s an example. A 31-year-old woman in excellent health from Virginia who wants five years of coverage that pays out $25,000 would get a quote for Haven Simple at just $4.78 per month. That same woman looking for a 30-year policy paying out $3 million would be quoted for a Haven Term policy that costs just $122.42 per month.

The range of costs, coverages, and ease of getting quotes and comparisons has helped Haven Life earn its stellar reputation. From over 1,000 TrustPilot reviews, it maintains an average rating of 4.8/5 stars. One user named Mark wrote of his experience: “The whole process was seamless and easy. My application for term life insurance was all done online. The rates are fair, and the people at Haven Life seem to genuinely care about their customers.” Newsweek agrees with the last sentiment, which is why it named Haven Life in its Best America Customer Service 2022 list.

Don’t waste any more time. Answer a few quick questions and discover how low your term life insurance from Haven Life can be.


Sponsored by Haven Life Insurance Agency.

Haven Term is a Term Life Insurance Policy (ICC21 HAVEN TERM in certain states, including NC; HAVEN TERM CA21 in California) issued by C.M. Life Insurance Company (C.M. Life), Enfield, CT 06082. In New York (DTC-NY) and in other states, it is issued by Massachusetts Mutual Life Insurance Company (MassMutual), Springfield, MA 01111-0001.

Haven Simple is a Simplified Issue Term Life Insurance Policy (ICC20 HAVEN SIMPLE in certain states, including NC) issued by C.M. Life Insurance Company, Enfield, CT 06082. Policy and rider form numbers and features may vary by state and may not be available in all states. Our Agency license number in California is OK71922 and in Arkansas 100139527.

1Coverage amount available for those ages 20-59 is up to $3M.

2Issuing the policy or paying its benefits depends on the applicant’s insurability, based on their answers to the health questions in the application and their truthfulness.

We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

The yield curve is no longer inverted, but inflation continues to rage higher as proven by the 11.2% reading for PPI today. However, this is a growing chorus of market commentators who see signs of “peak inflation” which means lower inflation ahead and potentially an all clear signal for the stock market (SPY). If only it were that easy. So let’s discuss what we know at this time leading to the best investment strategies to navigate these choppy waters in the weeks and months ahead. – StockNews

(Please enjoy this updated version of my weekly commentary from the Reitmeister Total Return newsletter).

The market consolidation and sector rotation stays in place. With that is range bound trading…but don’t confuse that for calm markets. We still endure violent volatility day to day and group by group.

2 trends continue to pay the bills: Energy and rising rate trades. We have aggressively overweighted each and enjoying the rewards as our portfolio is in positive territory on the year. But that doesn’t mean that everything is rainbows and lollipops.

So let’s dig in with the latest information to appreciate future market direction including the growing narrative that we are reaching “peak inflation”.

Market Commentary

Last week’s commentary (Bear Market Scare?: The Inverted Yield Curve) is a vital starting point for this week’s conversation. So make sure that you read it first and then move on with the additional insights below.

The first thing to point out is that the yield curve is still not inverted at this moment. In fact, the spread has widened nicely since the beginning of the month: 2.365% for 2 year vs. 2.703% for 10 year.

Next is the ideas confirmed in the FOMC Minutes from last week pointing out their aggressive plans to unwind more and more of their $9 Trillion (yes, Trillion) balance sheet of positions. And they will do that $90 billion a month for the foreseeable future.

This increased supply of Treasury bonds sold by the Fed will require higher rates to entice new buyers to snap them up given the state of inflation. And thus the inverted yield curve scare will fade more and more into the distance as the Fed releases more and more bonds into the market and longer term Treasury rates go higher and higher. This is clearly a positive for our 2 direct trades on higher rates and for the regional banks (3 tickers reserved for Reitmeister Total Return members…learn more about these trades here >).

So the idea that there is a recession warning out there from an inverted yield curve is becoming less and less valid. But indeed inflation is still high as proven by the CPI and PPI reports this week.

Now let’s transition to the related topic of peak inflation. There is now a growing number of Market Strategist claiming that inflation is likely topping out and thus heading lower in the future.

That was hard to see in the 11.2% year over year reading for PPI this morning. However, the economists who focus on these topics point to there being an artificial dip in prices last spring/summer that is making inflation look obscenely high now that will fade away. And when it does, then we will see rates moderate.

Just as you are breathing a sigh of relief, unfortunately, the next hoop to jump through is the GREAT HOPE that the Fed sees these signals clearly and does not overly remove accommodation (raise rates) and thus harm the economy. Yes, it is true that the Fed has a poor track record on this front. But since these folks are indeed students of history…then likely they have learned lessons from the past that will hopefully lead to better decisions this time around.

Hope is not a strategy which explains why investors are stuck between the highs of the year and the lows. The more proof that the Fed gets it right, and the economy continues to roll higher, the sooner stocks will break higher.

Conversely, if there are growing signs of economic damage from high inflation, then the more likely stocks will revisit the recent lows…and maybe lower.

Sorry that the pathway is not clearer…but economics is a soft science. Meaning its inexact. And thus its correlation to the future of stock prices is also not clear.

That is why we are leaning into the trends that are paying the bills (energy and rising rates trades). Staying away from industries harmed by higher rates and higher energy prices (home building, autos, trucking etc). And altogether staying nimble to move our portfolio more aggressive or conservative as will be necessary.

What To Do Next?

Discover my “Lucky 13 Trades” inside the Reitmeister Total Return portfolio that are perfect for this hectic market environment.

Note this newsletter service firmly beat the market last year. And actually in positive territory in 2022 as most other investors are enduring heavy losses.

How is that possible?

The clue is right there in the name: Reitmeister Total Return

Meaning this service was built to find positive returns in all market environments. Not just when the bull is running full steam ahead. Heck, anyone can profit in that environment.

Yet when stocks are trending sideways, or even worse, heading lower…then you need to employ a different set of strategies to be successful.

Come discover what 40 years of investing experience can do you for you.

Plus get immediate access to my full portfolio including the current “Lucky 13 Trades” that are primed to excel in this unique market environment. (This includes 3 little known investments that actually profit from rising rates).

Click Here to Learn More >

Wishing you a world of investment success!

Steve Reitmeister…but everyone calls me Reity (pronounced “Righty”)
CEO, Stock News Network and Editor, Reitmeister Total Return

SPY shares fell $0.23 (-0.05%) in after-hours trading Wednesday. Year-to-date, SPY has declined -6.37%, versus a % rise in the benchmark S&P 500 index during the same period.

About the Author: Steve Reitmeister

Steve is better known to the StockNews audience as “Reity”. Not only is he the CEO of the firm, but he also shares his 40 years of investment experience in the Reitmeister Total Return portfolio. Learn more about Reity’s background, along with links to his most recent articles and stock picks.


The post Peak Inflation and the Stock Market Outlook appeared first on

We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

Profitability Outlook Accelerated In Wake Of OrganiGram Results 

OrganiGram (NASDAQ: OGI) reached a turning point in Q1 in which profitability became truly in reach. The company updated its outlook for profitability from Q4 to Q3 of the current fiscal year and the outlook is accelerating again. The Q2 results were boosted by faster than expected realizations of synergies related to the Laurentian acquisition and should provide a tailwind to what was already a positive outlook for the company. The bottom line is that, after years of reorganization and waiting by the market, it looks like the bottom is in for OrganiGram stock and a rally is about to unfold. – MarketBeat

“We are also progressing well with the Laurentian integration. In less than three months we have been able to significantly increase distribution and begin to implement the synergies planned at acquisition. Automation to optimize production is also underway and expected to be complete by the end of Fiscal 2022.”

OrganiGram Turns Profits Two Quarters Ahead Of Schedule 

OrganiGram had a truly great quarter producing $31.84 million in sales for growth of 117.5% over last year. The sales are 2600 basis points ahead of the consensus and due in part to the Laurentian acquisition. Sales are also driven by the company’s efforts to improve its product line, deepen penetration within its home province, and grow into Canada’s other major cannabis markets. The company reports its market share hit 8.2% of the total for the 2nd month in a row and it is #1 in the dried-flower category. Dried flowers are Canada’s largest cannabis segment and more than 50% of all revenue so that is important news. 

Moving down the report, the news only gets better. The company reports its cost of sales fell 20% versus last year while impairments related to inventory fell by 26%. SG&A increased due to expansion and inflationary pressure but not enough to offset the revenue strength and reduction in costs. This left the adjusted gross margin at 26% and adjusted EBITDA at $1.6 million or 5.05% and in positive territory two full quarters ahead of earlier estimates. Based on the trajectory of the business, we see both revenue and margin improvement on a sequential basis for the next several quarters at least. 

“The additional revenue from Laurentian, and continued growth in recreational and B2B sales, combined with improving margins through improved operational efficiencies, allowed us to achieve positive Adjusted EBITDA two quarters earlier than originally projected,” stated Derrick West, Chief Financial Officer. “Our strong balance sheet and cash position as well as the completion of our facility expansion to meet market demand, positions us well to deliver sustained value to our shareholders.”

The Technical Outlook: OrganiGram Moves Above The 30-Day EMA 

Price action in OrganiGram has been bottoming over the past few months and now looks ready to move higher. The results plus the recent deal with Tilray (NASDAQ: TLRY) have the market poised for a rally and the indicators are consistent with this view. The stochastic is already firing a bullish signal low in the range and MACD is set up for the same. The risk is resistance at the $1.80 level but we think that will be broken fairly easily. The bigger risk is resistance at the $2.00 level which we think will be harder to break. A move above $2.00 would be bullish but if $2.00 can’t be overcome range-bound trading until the next big news comes out is the most likely scenario. 
OrganiGram’s Turnaround Begins To Blossom 

We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

Like retail investors, institutional investors aren’t always right. But they are often the largest owners of individual stocks—and thereby largely responsible for day-to-day market movements. contributor/ – MarketBeat

Learning who holds the most shares in a particular company can help investors understand what dictates stock price changes. When big institutions like hedge funds, mutual funds, and ETFs are in control, their actions typically rule the day. In other cases, corporate insiders that own a majority of shares can manipulate trading activity. 

Institutional investors are most commonly the largest shareholders of a given stock simply because they have the deepest pockets. They manage thousands of active and passive funds which collectively amass huge assets under management (AUM).

But when institutions have stakes in an unusually high portion of a company’s shares outstanding, it can signal that the so-called “smart money” knows something the little guy does not. 

The exceptionally high institutional interest in these three names should peak investors’ interest. 

Is Gentherm Stock Oversold? 

Investment managers and fund managers combined own 99% of Gentherm Incorporated (NASDAQ: THRM) equity. This information can be gleaned from 13F forms that these investors must file quarterly with the SEC. 

The maker of climate-controlled seats and other vehicle heating and cooling products has the attention of two firms in particular. Blackrock and Vanguard, which together manage more than $17 trillion in assets, own approximately 27% of Gentherm’s outstanding shares. The iShares Core S&P Small Cap ETF by itself has scooped up 7% of the shares, while a pair of popular Vanguard index funds together own 5%. 

Among active investment managers, J.P. Morgan’s Undiscovered Managers Behavioral Value Fund is the largest Gentherm stakeholder. This unique mutual fund focuses on small cap value stocks to which the market tends to “overreact to old, negative information and underreact to new positive information”. As part of this strategy, significant insider buying or repurchases are considered responses to overreactions on fundamentally sound companies. 

Gentherm fits the mold of an undervalued small cap in oversold territory. After climbing to an all-time high of $99 at the start of the year, a disproportionate selloff related to supply chain issues and broad market weakness has the stock trading around $70. With new growth opportunities in the medical industry forthcoming and a below industry average P/E ratio, look for Gentherm to heat back up. 

Why Do Investment Managers Love Integer Holdings?

Integer Holdings Corporation (NYSE: ITGR) is a medical device company that specializes in portable cardiovascular and neuromodulation products. All but 0.8% of the 33 million shares outstanding belong to institutional investors. 

Once again, Blackrock’s iShares and Vanguard are the largest shareholders with a combined ownership of nearly 30%. Integer Holdings is also a favorite of several actively managed small-cap value funds. The (Morningstar 5-star rated) Fuller & Thaler Behavioral Small Cap Equity Fund, which also uses a behavioral-based stock-picking approach, has it as one of its healthcare holdings. The Delaware Small Cap Value and Franklin Small Cap Value funds also call Integer one of their own.

It’s easy to see why the stock is popular among active managers. Integer has beat top and bottom line estimates in each of the last five quarters. Product demand has been strong of late after the pandemic delayed elective surgeries. Now holding a large order backlog, the company is expanding its manufacturing capacity to keep up with demand. With a forward P/E of 17x, institutions are heavily invested in Integer for good reason.

Is Bath & Body Works’ Stock Undervalued?

Bath & Body Works, Inc. (NYSE: BBWI) has a 97% institutional ownership. Investors that took a chance on the personal care and beauty products retailer at the depths of the pandemic low really cleaned up. 

The stock increased more than tenfold from March 2020 to November 2021 amid crazy demand for all things hygiene. Now down 45% from its record peak, however, Bath & Body Works appears to be circling the drain—but maybe not. 

Institutional shareholders have taken a bath during the current 4-month losing streak but aren’t yet ready to throw in the towel. While the company faces increased pressure from surging online competitors, a spinoff of the Victoria Secrets business has Bath & Body Works in a more flexible financial position to pursue growth in brick-and-mortar in addition to its own e-commerce channels.

As a 10% equity owner, Lone Pine Capital is still a big believer in this retail turnaround story. The Connecticut-based investment advisor has a 7% weighting in its concentrated equity strategy; only Amazon, Shopify, and Mastercard as larger positions. 

Due to the recent slide, Bath & Body Works is trading at less than 10x forward earnings. This one smells like an undervalued buy opportunity.

We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

Disclosure: Our goal is to feature products and services that we think you’ll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from our commerce partners.

As we get older, our priorities change — and not just in business. We have to learn how to take care of ourselves in ways we didn’t have to when we were younger. One good way to do that is by learning to better understand your body. While DNA tests are wildly popular for discovering ancestry, they have another useful application: Giving you a better perspective on your health. With The Complete SelfDecode DNA Test Kit, you can do just that.


This at-home DNA test uses saliva to go beyond your 23 chromosomes to determine personalized health insights, the company says. In just a few easy steps, you’ll unlock your unique genetic tendencies and markers that will help you better understand the kind of healthy lifestyle you should pursue. After a simple saliva test, you’ll get personalized supplement, diet, and lifestyle recommendations based on your DNA, and get one year of access to personalized health reports and traits that are updated regularly based on additional genetic information.

With the subscription, you’ll gain insight into your mood, blood pressure, gut issues, and more to help you make better choices for your health. All of SelfDecode’s reports are built on the latest AI and machine learning technology to ensure they’re consistently updated and reflective of all the data available. In addition to your subscription, you’ll have unlimited access to additional health tools like a regimen builder and lab analyzer to help you achieve health goals. Of course, your DNA is 100% protected and will never be shared with anybody unless you choose to share your results.

Find out why SelfDecode has earned 4.8 stars on Trustpilot. Right now, you can get The Complete SelfDecode DNA Test Kit + 1 Yr Subscription Bundle for 54 percent off $196 at just $89.

Prices subject to change.

We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

Human capital management and financial work flow solutions provider Workday (NASDAQ: WDAY) stock has bottomed with the market indexes as it mounts a recovery off its recent lows under $206. The enterprise cloud provider of its industry leading HCM applications and CFO suite of financial software tools continues to grow its top and bottom lines in the double-digits capitalizing the migration to the cloud. Whereas HCM software is traditionally used on-premises, the Company is the leader in cloud-based HCM and riding the migration and adoption of enterprise cloud as it pertains to both HCM and ERP. The Company is seeing strong growth internationally as sales surpassed the $1 billion mark in fiscal 2022 and bolstering its work force by 20% last year. Shares have been resilient in the wake of the Nasdaq market sell-off that briefly reached bear market (-20% off highs) status. Prudent investors seeking exposure in the HCM cloud migration tailwinds can watch for opportunistic pullbacks in shares of Workday. contributor/ – MarketBeat

Fiscal Q4 2022 Earnings Release

On Feb. 28, 2022, Workday released its fiscal fourth-quarter 2022 results for the quarter ended January 2022. The Company reported earnings-per-share (EPS) profits of $0.78 versus a profit of $0.71 consensus analyst estimates, an $0.07 beat. Revenues grew 21.6% year-over-year (YoY) to $1.38 billion, beating analyst estimates for $1.36 billion. Subscription revenues rose 22.2% to $1.23 billion. Total subscription backlog rose 26.9% YoY to $12.81 billion. Workday Co-CEO Aneel Bhusri commented, “We continue to see increasing demand for our broad suite of finance and HR solutions, as we help some of the world’s largest organizations – and more than 60 million users – navigate the changing world of work. This momentum, along with our employees’ continued commitment, gives me great confidence in the opportunity ahead.”

Conference Call Takeaways

Co-CEO Bhusri noted that its fiscal Q4 2022 achieved the fastest growth in new full-year ACV bookings in over five years, which is driving its growth towards the $10 billion annual revenue mark. Workday accommodates over 60 million users through 9,500 companies including 4.1K finance and HCM clients. It has a customer retention rate that surpasses 95%. Workday processed over 440 billion in transactions during fiscal 2022, up 67% YoY. The products are used by 50% of the Fortune 500 and over 25% of the Global 2000 companies. He noted that more companies are migrating their human capital management operations (HCM) to the cloud as evidenced by strong demand across their HCM portfolio of products. He mentioned a number of notable wins for the quarter including Allied Financial, Rite Aid, DICK’s Sporting Goods, 7-Eleven, U.S. Bank, Mass General Brigham, University of Melbourne and HCM go-lives including Wells Fargo and Anheuser-Busch InBev. Strong growth was evident in its core financial platform but also CFO tools including analytics, spending. “We continue to see very healthy attach rates for spend management solutions within our financial customers, illustrating health finances increasingly partnering with their procurement peers, drive visibility and bottom line impact for the single solution. and planning applications”, stated CEO Bhusri. Co-CEO Chano Fernandez raised guidance for fiscal 2023 subscription revenues to grow 22% to come in between $5.53 billion to $5.55 billion. He also raised 2023 non-GAAP operating margin to 18.5% as its market position as “never been stronger…”.

Workday Stock is Working its Recovery

WDAY Opportunistic Pullback Levels

Using the rifle charts on the weekly and daily time frames provides a precision view of the landscape for WDAY stock. The weekly rifle chart peaked near the $306.89 Fibonacci (fib) level before a breakdown plunge to $205.90. The weekly rifle chart downtrend has stalled as the 5-period moving average (MA) starts to slope up at $234.28 as it tightens to the 15-period MA at 244.60. The weekly 50-period MA sits at $251.51. The weekly market structure low (MSL) buy triggers on the breakout above $250.00. The weekly stochastic triggered a mini pup through the 20-band as it rises towards the 40-band. The daily rifle chart breakout is starting to lose steam as the daily 5-period MA starts to slope down at $240.49 along with a flat daily 50-period MA at $235.42 and 15-period MA at $232.16. The daily stochastic peaked under the 80-band and is testing a potential crossover down or a mini pup through the 80-band. Prudent investors can look for opportunistic pullbacks at the $225.40 fib, $222.47 fib, $215.76, $209.98 fib, $204.86, $200.80 fib, and the $197.79 fib level. Upside trajectories range from the $262.47 fib up towards the $293.37 fib level.


We are now available over telegram, Click here to subscribe to our telegram channel to receive regular updates straight to your phone.

Copyright © 2010 - 2022 Intellixa | All Rights Reserved


Click one of our representative below to connect over WhatsApp